drugset / Trial / NCT01446952
Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects
Phase 1
Completed
18 enrolled
H. Lee Moffitt Cancer Center and Research Institute
BioGene Life Science · collabNational Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelPrevention
Summary
This is a Phase 1, open-label, non-randomized, dose-finding, study of Vitamin E δ-Tocotrienol in subjects with resectable pancreatic tumors.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-09
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Delta-tocotrienol | Other / unclassified | 200 mg | Oral |